Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
Nov 12, 2021
|
| In: |
HemaSphere
Year: 2021, Volume: 5, Issue: 12, Pages: 1-4 |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/HS9.0000000000000664 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/HS9.0000000000000664 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/hemasphere/Fulltext/2021/12000/Obinutuzumab_in_Allogeneic_Transplantation_for_CLL.2.aspx |
| Author Notes: | Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL study group |
| Item Description: | Gesehen am 07.01.2022 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/HS9.0000000000000664 |